These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 15167900

  • 1. Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus.
    Lim HY, Ahn M, Chung HC, Gardner TA, Kao C, Lee SJ, Kim SJ.
    Cancer Gene Ther; 2004 Aug; 11(8):532-8. PubMed ID: 15167900
    [Abstract] [Full Text] [Related]

  • 2. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma.
    Liu Y, Ye T, Sun D, Maynard J, Deisseroth A.
    Hum Gene Ther; 2004 Jul; 15(7):637-47. PubMed ID: 15242524
    [Abstract] [Full Text] [Related]

  • 3. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X, Jung C, Liu YH, Bae KH, Zhang YP, Zhang HJ, Vanderputten D, Jeng MH, Gardner TA, Kao C.
    J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
    [Abstract] [Full Text] [Related]

  • 4. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
    Zhang M, Zhang X, Han Z, Chen X, Yang L, Sheng Y, Wen J.
    Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H, Zhang L, Tang Y, Deisseroth A.
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [Abstract] [Full Text] [Related]

  • 6. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B, Liu X, Fan J, Qi R, Bo L, Gu J, Qian Q, Qian C, Liu X.
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [Abstract] [Full Text] [Related]

  • 7. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
    Zhang J, Wei F, Wang H, Li H, Qiu W, Ren P, Chen X, Huang Q.
    Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
    [Abstract] [Full Text] [Related]

  • 8. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H, Wei F, Li H, Ji X, Li S, Chen X.
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [Abstract] [Full Text] [Related]

  • 9. Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene.
    Hernández JM, Bui MH, Han KR, Mukouyama H, Freitas DG, Nguyen D, Caliliw R, Shintaku PI, Paik SH, Tso CL, Figlin RA, Belldegrun AS.
    Clin Cancer Res; 2003 May; 9(5):1906-16. PubMed ID: 12738749
    [Abstract] [Full Text] [Related]

  • 10. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL, Ryan P, Gorziglia M, Clarke L, Hawkins LK, Hay C, Huang Y, Kaloss M, Marinov A, Phipps S, Pinkstaff A, Shirley P, Skripchenko Y, Stewart D, Forry-Schaudies S, Hallenbeck PL.
    Cancer Res; 2003 Apr 01; 63(7):1490-9. PubMed ID: 12670895
    [Abstract] [Full Text] [Related]

  • 11. Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor.
    Cho WK, Seong YR, Lee YH, Kim MJ, Hwang KS, Yoo J, Choi S, Jung CR, Im DS.
    Mol Ther; 2004 Nov 01; 10(5):938-49. PubMed ID: 15509511
    [Abstract] [Full Text] [Related]

  • 12. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
    Jakubicková L, Biesová Z, Pastoreková S, Kettmann R, Pastorek J.
    Int J Oncol; 2005 Apr 01; 26(4):1121-7. PubMed ID: 15754010
    [Abstract] [Full Text] [Related]

  • 13. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
    Ahn WS, Bae SM, Lee KH, Lee JM, Namkoong SE, Chun HJ, Kim CK, Kim YW.
    Gynecol Oncol; 2004 Feb 01; 92(2):611-21. PubMed ID: 14766255
    [Abstract] [Full Text] [Related]

  • 14. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.
    Maemondo M, Saijo Y, Narumi K, Kikuchi T, Usui K, Tazawa R, Matsumoto K, Nakamura T, Sasaki K, Takahashi M, Niitsu Y, Nukiwa T.
    Cancer Res; 2004 Jul 01; 64(13):4611-20. PubMed ID: 15231673
    [Abstract] [Full Text] [Related]

  • 15. Study of in vitro conditions modulating expression of MN/CA IX protein in human cell lines derived from cervical carcinoma.
    Lieskovská J, Opavský R, Záciková L, Glasová M, Pastorek J, Pastoreková S.
    Neoplasma; 1999 Jul 01; 46(1):17-24. PubMed ID: 10355529
    [Abstract] [Full Text] [Related]

  • 16. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME, Beard BC, Lieber A, Kiem HP.
    Cancer Res; 2007 Sep 15; 67(18):8783-90. PubMed ID: 17875719
    [Abstract] [Full Text] [Related]

  • 17. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y, Yu DC, Chen Y, Amin P, Zhang H, Nguyen N, Henderson DR.
    Cancer Res; 2001 Sep 01; 61(17):6428-36. PubMed ID: 11522637
    [Abstract] [Full Text] [Related]

  • 18. Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy.
    Hsu KF, Wu CL, Huang SC, Hsieh JL, Huang YS, Chen YF, Shen MR, Chung WJ, Chou CY, Shiau AL.
    Cancer Gene Ther; 2008 Aug 01; 15(8):526-34. PubMed ID: 18497852
    [Abstract] [Full Text] [Related]

  • 19. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
    Matsubara S, Wada Y, Gardner TA, Egawa M, Park MS, Hsieh CL, Zhau HE, Kao C, Kamidono S, Gillenwater JY, Chung LW.
    Cancer Res; 2001 Aug 15; 61(16):6012-9. PubMed ID: 11507044
    [Abstract] [Full Text] [Related]

  • 20. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.
    Irving J, Wang Z, Powell S, O'Sullivan C, Mok M, Murphy B, Cardoza L, Lebkowski JS, Majumdar AS.
    Cancer Gene Ther; 2004 Mar 15; 11(3):174-85. PubMed ID: 14726958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.